AAPL321.42-4.47 (-1.37%) ▼|ABBV257.38+4.08 (+1.61%) ▲|ABT100.77+0.20 (+0.20%) ▲|ACN138.23-1.86 (-1.33%) ▼|ADBE213.31-5.05 (-2.31%) ▼|AMAT565.52+11.60 (+2.09%) ▲|AMD542.30-10.03 (-1.82%) ▼|AMGN367.21+1.16 (+0.32%) ▲|AMT166.92+0.86 (+0.52%) ▲|AMZN234.30-10.55 (-4.31%) ▼|AVGO390.31-6.50 (-1.64%) ▼|AXP341.72-7.02 (-2.01%) ▼|BA208.58-0.07 (-0.03%) ▼|BAC61.04-0.58 (-0.94%) ▼|BKNG172.85-5.01 (-2.82%) ▼|BLK1,042.19-14.45 (-1.37%) ▼|BMY61.65+0.89 (+1.46%) ▲|BNY159.63-0.76 (-0.47%) ▼|BRK-B489.34-0.05 (-0.01%) ▼|C131.86-0.39 (-0.29%) ▼|CAT907.56+18.25 (+2.05%) ▲|CL89.86-1.77 (-1.93%) ▼|CMCSA23.02-0.51 (-2.15%) ▼|COF196.60-4.77 (-2.37%) ▼|COP121.79+3.00 (+2.53%) ▲|COST917.57-9.74 (-1.05%) ▼|CRM157.94-5.06 (-3.10%) ▼|CSCO113.21+1.00 (+0.89%) ▲|CVS106.68-0.74 (-0.69%) ▼|CVX197.39+4.41 (+2.29%) ▲|DE610.83+3.50 (+0.58%) ▲|DHR185.85+6.71 (+3.75%) ▲|DIS93.03-2.84 (-2.96%) ▼|DUK128.64+0.69 (+0.54%) ▲|EMR145.17+5.54 (+3.96%) ▲|FDX318.17-2.85 (-0.89%) ▼|GD383.99+10.83 (+2.90%) ▲|GE348.79+7.60 (+2.23%) ▲|GEV1,021.24+36.21 (+3.68%) ▲|GILD128.97-1.37 (-1.05%) ▼|GM79.25-2.88 (-3.51%) ▼|GOOG317.89-24.02 (-7.03%) ▼|GOOGL318.81-23.29 (-6.81%) ▼|GS1,074.15-24.05 (-2.19%) ▼|HD325.82-5.63 (-1.70%) ▼|HON247.04+14.05 (+6.03%) ▲|IBM206.29+0.52 (+0.25%) ▲|INTC103.61+0.99 (+0.97%) ▲|INTU282.62-1.85 (-0.65%) ▼|ISRG329.41-11.28 (-3.31%) ▼|JNJ255.92+0.29 (+0.11%) ▲|JPM347.23-0.98 (-0.28%) ▼|KO81.23-0.97 (-1.18%) ▼|LIN507.39-1.29 (-0.25%) ▼|LLY1,172.68+9.67 (+0.83%) ▲|LMT572.24+57.88 (+11.25%) ▲|LOW201.67-2.68 (-1.31%) ▼|LRCX324.61+5.32 (+1.67%) ▲|MA526.67-5.32 (-1.00%) ▼|MCD262.17-1.40 (-0.53%) ▼|MDLZ60.18-0.68 (-1.12%) ▼|MDT82.15+0.26 (+0.32%) ▲|META605.54-21.63 (-3.45%) ▼|MMM169.96-0.80 (-0.47%) ▼|MO72.27+0.10 (+0.14%) ▲|MRK129.66+2.19 (+1.72%) ▲|MS215.31-3.19 (-1.46%) ▼|MSFT383.62-6.73 (-1.72%) ▼|MU994.19+34.71 (+3.62%) ▲|NEE89.75+0.34 (+0.37%) ▲|NFLX68.31-0.22 (-0.32%) ▼|NKE41.20-1.02 (-2.40%) ▼|NOW97.16+1.70 (+1.78%) ▲|NVDA208.23-3.83 (-1.81%) ▼|ORCL123.64-2.21 (-1.75%) ▼|PEP134.22-1.44 (-1.06%) ▼|PFE24.90+0.08 (+0.30%) ▲|PG146.26-2.88 (-1.93%) ▼|PLTR123.38-1.19 (-0.96%) ▼|PM192.93-1.37 (-0.71%) ▼|QCOM172.54-3.09 (-1.76%) ▼|RTX209.65+14.77 (+7.58%) ▲|SBUX102.55-1.44 (-1.38%) ▼|SCHW102.30+1.50 (+1.49%) ▲|SO95.91+0.11 (+0.11%) ▲|SPG227.16+0.94 (+0.42%) ▲|T22.77-0.27 (-1.17%) ▼|TMO572.49+46.03 (+8.74%) ▲|TMUS180.64-10.30 (-5.39%) ▼|TSLA325.75-48.26 (-12.90%) ▼|TXN283.14-11.05 (-3.76%) ▼|UBER69.67-0.67 (-0.95%) ▼|UNH420.81-10.50 (-2.43%) ▼|UNP309.77+17.21 (+5.88%) ▲|UPS115.45-0.40 (-0.34%) ▼|USB63.15-1.32 (-2.05%) ▼|V349.45-3.97 (-1.12%) ▼|VZ44.29+0.00 (+0.00%) ▲|WFC85.78-0.64 (-0.74%) ▼|WMT107.08-2.25 (-2.06%) ▼|XOM157.81+3.36 (+2.18%) ▲|AAPL321.42-4.47 (-1.37%) ▼|ABBV257.38+4.08 (+1.61%) ▲|ABT100.77+0.20 (+0.20%) ▲|ACN138.23-1.86 (-1.33%) ▼|ADBE213.31-5.05 (-2.31%) ▼|AMAT565.52+11.60 (+2.09%) ▲|AMD542.30-10.03 (-1.82%) ▼|AMGN367.21+1.16 (+0.32%) ▲|AMT166.92+0.86 (+0.52%) ▲|AMZN234.30-10.55 (-4.31%) ▼|AVGO390.31-6.50 (-1.64%) ▼|AXP341.72-7.02 (-2.01%) ▼|BA208.58-0.07 (-0.03%) ▼|BAC61.04-0.58 (-0.94%) ▼|BKNG172.85-5.01 (-2.82%) ▼|BLK1,042.19-14.45 (-1.37%) ▼|BMY61.65+0.89 (+1.46%) ▲|BNY159.63-0.76 (-0.47%) ▼|BRK-B489.34-0.05 (-0.01%) ▼|C131.86-0.39 (-0.29%) ▼|CAT907.56+18.25 (+2.05%) ▲|CL89.86-1.77 (-1.93%) ▼|CMCSA23.02-0.51 (-2.15%) ▼|COF196.60-4.77 (-2.37%) ▼|COP121.79+3.00 (+2.53%) ▲|COST917.57-9.74 (-1.05%) ▼|CRM157.94-5.06 (-3.10%) ▼|CSCO113.21+1.00 (+0.89%) ▲|CVS106.68-0.74 (-0.69%) ▼|CVX197.39+4.41 (+2.29%) ▲|DE610.83+3.50 (+0.58%) ▲|DHR185.85+6.71 (+3.75%) ▲|DIS93.03-2.84 (-2.96%) ▼|DUK128.64+0.69 (+0.54%) ▲|EMR145.17+5.54 (+3.96%) ▲|FDX318.17-2.85 (-0.89%) ▼|GD383.99+10.83 (+2.90%) ▲|GE348.79+7.60 (+2.23%) ▲|GEV1,021.24+36.21 (+3.68%) ▲|GILD128.97-1.37 (-1.05%) ▼|GM79.25-2.88 (-3.51%) ▼|GOOG317.89-24.02 (-7.03%) ▼|GOOGL318.81-23.29 (-6.81%) ▼|GS1,074.15-24.05 (-2.19%) ▼|HD325.82-5.63 (-1.70%) ▼|HON247.04+14.05 (+6.03%) ▲|IBM206.29+0.52 (+0.25%) ▲|INTC103.61+0.99 (+0.97%) ▲|INTU282.62-1.85 (-0.65%) ▼|ISRG329.41-11.28 (-3.31%) ▼|JNJ255.92+0.29 (+0.11%) ▲|JPM347.23-0.98 (-0.28%) ▼|KO81.23-0.97 (-1.18%) ▼|LIN507.39-1.29 (-0.25%) ▼|LLY1,172.68+9.67 (+0.83%) ▲|LMT572.24+57.88 (+11.25%) ▲|LOW201.67-2.68 (-1.31%) ▼|LRCX324.61+5.32 (+1.67%) ▲|MA526.67-5.32 (-1.00%) ▼|MCD262.17-1.40 (-0.53%) ▼|MDLZ60.18-0.68 (-1.12%) ▼|MDT82.15+0.26 (+0.32%) ▲|META605.54-21.63 (-3.45%) ▼|MMM169.96-0.80 (-0.47%) ▼|MO72.27+0.10 (+0.14%) ▲|MRK129.66+2.19 (+1.72%) ▲|MS215.31-3.19 (-1.46%) ▼|MSFT383.62-6.73 (-1.72%) ▼|MU994.19+34.71 (+3.62%) ▲|NEE89.75+0.34 (+0.37%) ▲|NFLX68.31-0.22 (-0.32%) ▼|NKE41.20-1.02 (-2.40%) ▼|NOW97.16+1.70 (+1.78%) ▲|NVDA208.23-3.83 (-1.81%) ▼|ORCL123.64-2.21 (-1.75%) ▼|PEP134.22-1.44 (-1.06%) ▼|PFE24.90+0.08 (+0.30%) ▲|PG146.26-2.88 (-1.93%) ▼|PLTR123.38-1.19 (-0.96%) ▼|PM192.93-1.37 (-0.71%) ▼|QCOM172.54-3.09 (-1.76%) ▼|RTX209.65+14.77 (+7.58%) ▲|SBUX102.55-1.44 (-1.38%) ▼|SCHW102.30+1.50 (+1.49%) ▲|SO95.91+0.11 (+0.11%) ▲|SPG227.16+0.94 (+0.42%) ▲|T22.77-0.27 (-1.17%) ▼|TMO572.49+46.03 (+8.74%) ▲|TMUS180.64-10.30 (-5.39%) ▼|TSLA325.75-48.26 (-12.90%) ▼|TXN283.14-11.05 (-3.76%) ▼|UBER69.67-0.67 (-0.95%) ▼|UNH420.81-10.50 (-2.43%) ▼|UNP309.77+17.21 (+5.88%) ▲|UPS115.45-0.40 (-0.34%) ▼|USB63.15-1.32 (-2.05%) ▼|V349.45-3.97 (-1.12%) ▼|VZ44.29+0.00 (+0.00%) ▲|WFC85.78-0.64 (-0.74%) ▼|WMT107.08-2.25 (-2.06%) ▼|XOM157.81+3.36 (+2.18%) ▲|
23.7 C
New York
Thursday, July 23, 2026

Tag: Paris:SAN

newssourceFORcompanyinformationcontent1releasesmarket

Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase...

EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study

Communiqué : Dupixent a démontré sa supériorité par rapport au Xolair dans la rhinosinusite chronique avec polypes nasaux chez des patients atteints d’asthme coexistant...

EAACI : Le Dupixent a démontré sa supériorité par rapport au Xolair (omalizumab) dans la rhinosinusite chronique avec polypes nasaux chez des patients atteints d’asthme coexistant dans la toute première étude respiratoire de phase 4 en comparaison directe jamais présentée

Sanofi: Information concerning the total number of voting rights and shares – May 2025

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority)

Sanofi: Informations relatives au nombre de droits de vote et d’actions – Mai 2025

Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers

Press Release: Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season

Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season

Communiqué de presse : Sanofi accélère la livraison mondiale de Beyfortus pour préparer les professionnels de santé plusieurs mois avant la saison 2025-2026 de...

Sanofi accélère la livraison mondiale de Beyfortus pour préparer les professionnels de santé plusieurs mois avant la saison 2025-2026 de VRS

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsParis:SAN

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers